Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis
HIV Medicine · 2026-01 · 27 (1) · 96-105
DOI: 10.1111/hiv.70119 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift HIV Medicine, online erschienen am 07.10.2025. Verfasst von Gundolf Schuettfort und 21 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Frankfurt, Frankfurt, Germany. Hauptthemen laut MEDLINE: HIV Infections, Lamivudine, Anti-HIV Agents, Anti-Retroviral Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Objective
To investigate the efficacy and safety of first‐line antiretroviral treatment (ART) with 2DR dolutegravir/lamivudine (DTG/3TC) versus 3DR bictegravir/tenofovir alafenamide/emtricitabine (BIC/TAF/FTC) in persons with low CD4 cell counts and/or an AIDS‐defining disease.
Design
Retrospective, multicentre, multinational study.
Methods
We conducted a retrospective, multicentre, multinational analysis to investigate the virological response and discontinuation rate in people living with HIV starting first‐line ART with a CD4 cell count
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Hospital Frankfurt, Frankfurt, Germany.
- Praxis Goldstein, Berlin, Germany.
- Hospital Universitario Fundacion Jimenez Diaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, (IIS-FJD, UAM), Madrid, Spain.
- Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
- Hospital Universitario Virgen de las Nieves, Granada, Spain.
- Hospital Universitario Gregorio Maranon, Madrid, Spain.
ORCID-Profile: Gundolf Schuettfort, Alfonso Cabello, Carmen Hidalgo-Tenorio, Rafael Mican, Juergen Rockstroh, Christoph Stephan
Zitieren
APA
Schuettfort, G., Borch, J., Cabello, A., Crusells, M., Górgolas, M., Herrmann, E., Hidalgo-Tenorio, C., Lopez, J., Mican, R., Navarro-Soler, R., Negredo, E., Noe, S., Puig, J., Pulido, F., Serrao, R., Rockstroh, J., Rodriguez, S., Stephan, C., Torralba, M., …, & Haberl, A. E. (2026). Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis. HIV Medicine, 27(1), 96-105. https://doi.org/10.1111/hiv.70119
Vancouver
Schuettfort G, Borch J, Cabello A, Crusells M, Górgolas M, Herrmann E, et al. Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis. HIV Medicine. 2026;27(1):96-105. doi:10.1111/hiv.70119
BibTeX
@article{Schuettfort2026,
author = {Schuettfort, Gundolf and Borch, Jan and Cabello, Alfonso and Crusells, Maria and Górgolas, Miguel and Herrmann, Eva and Hidalgo-Tenorio, Carmen and Lopez, Juan and Mican, Rafael and Navarro-Soler, Roser and Negredo, Eugenia and Noe, Sebastian and Puig, Jordi and Pulido, Federico and Serrao, Rosario and Rockstroh, Juergen and Rodriguez, Sergio and Stephan, Christoph and Torralba, Miguel and Trigo, Diva and Vehreschild, Maria and Haberl, Annette E},
title = {Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis},
journal = {HIV Medicine},
year = {2026},
volume = {27},
number = {1},
pages = {96--105},
doi = {10.1111/hiv.70119}
}
EUVIMED